Evidence map›Paper›PMID 9547341›Full record

ArticleThe Journal of experimental medicine1998

Impaired interleukin 4 signaling in T helper type 1 cells.

H Huang, W E Paul

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  6. Article
  7. Article
  8. Sensitivity and resistance to regulation by IL-4 during Th17 maturation.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
  9. Review
  10. Review
  11. Article
  12. IL-23 promotes maintenance but not commitment to the Th17 lineage.Journal of immunology (Baltimore, Md. : 1950) · 2008
    Article
  13. Article
  14. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2008
    Article
  15. Article
  16. Review
  17. Article
  18. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

H HuangLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892, USA.
W E Paul
National Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cluster of differentation (CD)4+ T helper cells (Th)1s fail to produce interleukin (IL)-4. Even if restimulated in the presence of IL-4, a condition that induces IL-4-producing capacity in naive CD4+ T cells, Th1s fail to become IL-4 producers. We report that Th1 cells have a major impairment in IL-4 signaling. When compared to both Th2s and naive T cells, they display a striking diminution in phosphorylation of Stat6. They also show reduced phosphorylation of Janus kinase (JAK)-3 and insulin receptor substrate (IRS)-2 when compared to Th2s. Stat6 and JAK-3 are present in equivalent amounts in Th1s and Th2s, but IRS-2 protein levels are much lower in Th1s than in Th2s. Altered sensitivity to IL-4, the major inducer of the Th2 phenotype, may explain the stability of the Th1 state.

Indexed as

AnimalsCells, CulturedDose-Response Relationship, DrugInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsJanus Kinase 3MicePhosphoproteinsPhosphorylationProtein-Tyrosine KinasesReceptors, Interleukin-4Signal TransductionSTAT6 Transcription FactorTh1 CellsTh2 CellsInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsIrs2 protein, mouseJak3 protein, mouseJanus Kinase 3PhosphoproteinsProtein-Tyrosine KinasesReceptors, Interleukin-4Stat6 protein, mouseSTAT6 Transcription FactorTrans-Activators

Identifiers

PMID9547341
PMCPMC2212231
OpenAlexW2085530531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.